Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Anu Moilanen
Institution:
Orion Corporation (Finland)
Observed institutions:
University of Helsinki,
Orion Corporation (Finland)
OpenAlex ID:
A5110172886
Mutual Transcriptional Interference between RelA and Androgen Receptor
1996
·
Jorma J. Palvimo
, Piia Reinikainen
, et al.
·
Journal of Biological Chemistry
·
214
Discovery of Pyridyl Bis(oxy)dibenzimidamide Derivatives as Selective Matriptase Inhibitors
2013
·
Rajeev Goswami
, Subhendu Mukherjee
, et al.
·
ACS Medicinal Chemistry Letters
·
28
ODM-201, a new generation androgen receptor inhibitor for castration-resistant prostate cancer: Preclinical and phase I data.
2013
·
Karim Fizazi
, Christophe Massard
, et al.
·
Journal of Clinical Oncology
·
27
Faulty Epithelial Polarity Genes and Cancer
2011
·
Topi A. Tervonen
, Johanna I. Partanen
, et al.
·
Advances in cancer research
·
24
Discovery and development of ODM-204: A Novel nonsteroidal compound for the treatment of castration-resistant prostate cancer by blocking the androgen receptor and inhibiting CYP17A1
2018
·
Riikka Oksala
, Anu Moilanen
, et al.
·
The Journal of Steroid Biochemistry and Molecular Biology
·
23
PDF
Structure-guided discovery of 1,3,5 tri-substituted benzenes as potent and selective matriptase inhibitors exhibiting in vivo antitumor efficacy
2014
·
Rajeev Goswami
, Subhendu Mukherjee
, et al.
·
Bioorganic & Medicinal Chemistry
·
19
Structure-guided discovery of 2-aryl/pyridin-2-yl-1H-indole derivatives as potent and selective hepsin inhibitors
2015
·
Rajeev Goswami
, Gerd Wohlfahrt
, et al.
·
Bioorganic & Medicinal Chemistry Letters
·
14
Abstract 1753: Targeting cancer with selective cbp/p300 bromodomain inhibitors
2020
·
Mahaboobi Jaleel
, Ramesh S. Senaiar
, et al.
·
Cancer Research
·
2
Translational Science
2023
·
Outi Vaarala
, Sammeli Liikkanen
, et al.
·
Royal Society of Chemistry eBooks
·
1
ODM-204, a novel dual inhibitor of CYP17A1 and androgen receptor for the treatment of castration-resistant prostate cancer.
2016
·
Pekka Kallio
, Riikka Oksala
, et al.
·
Journal of Clinical Oncology
·
1
ODM-204: A novel dual inhibitor of CYP17A1 and androgen receptor for the treatment of castration-resistant prostate cancer—Preclinical data.
2015
·
Riikka Oksala
, Anu Moilanen
, et al.
·
Journal of Clinical Oncology
·
1
Abstract 6179: Comparative study of Polθ helicase and polymerase inhibitor biochemical and cellular potency
2023
·
Johanna K. Ahlskog
, Antti Pohjakallio
, et al.
·
Cancer Research
Abstract 1754: First in class orally bioavailable BETBRD degraders
2020
·
Chandrasekhar Abbineni
, Mahaboobi Jaleel
, et al.
·
Cancer Research
a selective matriptase inhibitor blocks tumor growth and metastasis while displaying potent antiangiogenic activity in an orthotopic murine renal cell cancer model
2018
·
Leena K. Satyam
, Rajeev Goswami
, et al.
·
Journal of Oncology Research and Therapy
Abstract 4133: ODM-203, a novel, selective and balanced FGFR and VEGFR inhibitor with strong activity on primary and metastatic tumor growth in FGFR-dependent and angiogenic cancer models
2015
·
Tim Holmström
, Anu Moilanen
, et al.
·
Cancer Research
Show more works
View as search
Works count:
15
Citation count:
354
H-index:
7
I10-index:
7
Year
Topic
Type
